Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
intramuscular injection
|
| gptkbp:alternativeName |
gptkb:CoviVac
KoviVac |
| gptkbp:approvalYear |
February 2021
|
| gptkbp:approvedBy |
gptkb:Russia
|
| gptkbp:clinicalTrialPhase |
Phase III (as of 2021)
|
| gptkbp:countryOfOrigin |
gptkb:Russia
|
| gptkbp:developedBy |
Chumakov Center
|
| gptkbp:dosingRegimen |
two doses
|
| https://www.w3.org/2000/01/rdf-schema#label |
KoviVac COVID-19 vaccine
|
| gptkbp:intervalBetweenDoses |
14 days
|
| gptkbp:manufacturer |
gptkb:Chumakov_Federal_Scientific_Center_for_Research_and_Development_of_Immune-and-Biological_Products_of_Russian_Academy_of_Sciences
|
| gptkbp:storage |
2-8°C
|
| gptkbp:target |
gptkb:COVID-19
|
| gptkbp:type |
inactivated virus vaccine
|
| gptkbp:WHOApprovalStatus |
not approved by WHO (as of 2024)
|
| gptkbp:bfsParent |
gptkb:Chumakov_Institute
|
| gptkbp:bfsLayer |
7
|